Literature DB >> 15326295

Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication.

Matthew J Evans1, Charles M Rice, Stephen P Goff.   

Abstract

The study of the hepatitis C virus (HCV) has been hindered by the lack of in vitro model systems. The recent development of HCV subgenomic RNA replicons has permitted the study of viral RNA replication in cell culture; however, the requirements for efficient replication of replicons in this system are poorly understood. Many viral isolates do not function as replicons and most require conserved changes, termed adaptive mutations, to replicate efficiently. In this report, we focus on the HCV nonstructural protein 5A (NS5A), a frequent locus for adaptive mutation. We found the interaction between NS5A and human vesicle-associated membrane protein-associated protein A (hVAP-A), a cellular target N-ethylmaleimide-sensitive factor attachment protein receptor, to be required for efficient RNA replication: NS5A mutations that blocked interaction with hVAP-A strongly reduced HCV RNA replication. Further analyses revealed an inverse correlation between NS5A phosphorylation and hVAP-A interaction. A subset of the previously identified adaptive mutations suppressed NS5A hyperphosphorylation and promoted hVAP-A binding. Our results support a model in which NS5A hyperphosphorylation disrupts interaction with hVAP-A and negatively regulates viral RNA replication, suggesting that replicon-adaptive mutations act by preventing the phosphorylation-dependent dissociation of the RNA replication complex. Copyright 2004 The National Academy of Sciencs of the USA

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326295      PMCID: PMC516513          DOI: 10.1073/pnas.0405152101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Detection of protein-protein interactions using different vectors in the two-hybrid system.

Authors:  P Legrain; M C Dokhelar; C Transy
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

2.  Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.

Authors:  Y Shi; K Alin; S P Goff
Journal:  Genes Dev       Date:  1995-11-01       Impact factor: 11.361

3.  Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus.

Authors:  Jing Zhang; Osamu Yamada; Takashi Sakamoto; Hiroshi Yoshida; Takahiro Iwai; Yoshihisa Matsushita; Hideo Shimamura; Hiromasa Araki; Kunitada Shimotohno
Journal:  Virology       Date:  2004-03-01       Impact factor: 3.616

4.  Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A.

Authors:  Y Tanji; T Kaneko; S Satoh; K Shimotohno
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

5.  Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro.

Authors:  Nobuyuki Kato; Kazuo Sugiyama; Katsuyuki Namba; Hiromichi Dansako; Takashi Nakamura; Marika Takami; Kazuhito Naka; Akito Nozaki; Kunitada Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  2003-07-04       Impact factor: 3.575

6.  Sequence and mutational analysis of ESS1, a gene essential for growth in Saccharomyces cerevisiae.

Authors:  S D Hanes; P R Shank; K A Bostian
Journal:  Yeast       Date:  1989 Jan-Feb       Impact factor: 3.239

7.  Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B.

Authors:  J O Koch; R Bartenschlager
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

8.  Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture.

Authors:  Keril J Blight; Jane A McKeating; Joseph Marcotrigiano; Charles M Rice
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

9.  Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft.

Authors:  Lu Gao; Hideki Aizaki; Jian-Wen He; Michael M C Lai
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  High-throughput screening of the yeast kinome: identification of human serine/threonine protein kinases that phosphorylate the hepatitis C virus NS5A protein.

Authors:  Carlos Coito; Deborah L Diamond; Petra Neddermann; Marcus J Korth; Michael G Katze
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  134 in total

1.  Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.

Authors:  Shuanghu Liu; Cassie A Nelson; Li Xiao; Ling Lu; Punit P Seth; Darrell R Davis; Curt H Hagedorn
Journal:  Antiviral Res       Date:  2010-11-12       Impact factor: 5.970

Review 2.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

3.  An RNA-binding protein, hnRNP A1, and a scaffold protein, septin 6, facilitate hepatitis C virus replication.

Authors:  Chon Saeng Kim; Su Kyoung Seol; Ok-Kyu Song; Ji Hoon Park; Sung Key Jang
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 4.  Cell culture systems for the hepatitis C virus.

Authors:  Gilles Duverlie; Czeslaw Wychowski
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

Review 5.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

6.  Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant.

Authors:  Artur Kaul; Ilka Woerz; Philip Meuleman; Geert Leroux-Roels; Ralf Bartenschlager
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

7.  Echocardiogram study to evaluate the effect of the novel hepatitis C virus NS5A inhibitor GSK2336805 on cardiac contractility in healthy subjects.

Authors:  D A Wilfret; K K Adkison; L A Jones; Y Lou; J Gan; W Spreen
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

8.  Identification of novel human kinases that suppress hepatitis C virus infection.

Authors:  A Lee; S Liu; T Wang
Journal:  J Viral Hepat       Date:  2013-11-10       Impact factor: 3.728

9.  Ubiquitination of tombusvirus p33 replication protein plays a role in virus replication and binding to the host Vps23p ESCRT protein.

Authors:  Daniel Barajas; Peter D Nagy
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

10.  Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.

Authors:  Feng Yang; Jason M Robotham; Heather B Nelson; Andre Irsigler; Rachael Kenworthy; Hengli Tang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.